<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01065233</url>
  </required_header>
  <id_info>
    <org_study_id>BRD/07/08-M</org_study_id>
    <nct_id>NCT01065233</nct_id>
  </id_info>
  <brief_title>Pangenomic Study During Alcoholic Cirrhosis</brief_title>
  <acronym>CDCHC</acronym>
  <official_title>Genetical Predisposition in Hepatocellular Carcinoma : Pangenomic Link Study During Alcoholic Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <brief_summary>
    <textblock>
      Hepatocellular carcinoma (HCC) is a frequent complication of cirrhosis. Occurrence of HCC&#xD;
      could be linked with multiple functional region of genome.&#xD;
&#xD;
      The determining of a genomic mapping of &quot; single nucleotide polymorphisms &quot; (SNPs) permit to&#xD;
      perform some genetic link studies with pathologies without clear hereditary disposition.&#xD;
&#xD;
      In this study, the investigators will identify predictives genetic polymorphism of HCC.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 23, 2008</start_date>
  <completion_date type="Actual">July 20, 2013</completion_date>
  <primary_completion_date type="Actual">December 27, 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Existence of HCC and Pangenomic analysis of DNA polymorphism</measure>
    <description>Existence of HCC and determination of which genetic polymorphism are predisposing to HCC or preventing for HCC</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cirrhosis severity (compensated or not)</measure>
    <description>Analysis of the genetic polymorphism involved in the severity of cirrhosis</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1325</enrollment>
  <condition>Alcoholic Cirrhosis</condition>
  <arm_group>
    <arm_group_label>alcoholic cirrhosis with viral infection</arm_group_label>
    <description>patient with alcoholic cirrhosis with viral infection (300 patients)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alcoholic cirrhosis without viral infection</arm_group_label>
    <description>patient with alcoholic cirrhosis without viral infection</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>DNA extraction</intervention_name>
    <description>DNA extraction of blood sample for DNAship analysis</description>
    <arm_group_label>alcoholic cirrhosis with viral infection</arm_group_label>
    <arm_group_label>alcoholic cirrhosis without viral infection</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      2 blood samples of 5ml for DNA extraction&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        2 groups with 2 subgroups:&#xD;
&#xD;
          -  patient with HCC&#xD;
&#xD;
          -  HCC with Child A&#xD;
&#xD;
          -  HCC with Child B/C&#xD;
&#xD;
          -  patient without HCC&#xD;
&#xD;
          -  Child A without HCC&#xD;
&#xD;
          -  Child B/C without HCC&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  35 to 70 years old&#xD;
&#xD;
          -  Compensated cirrhosis or not&#xD;
&#xD;
          -  Caucasian origin of the parents&#xD;
&#xD;
          -  Patient with cirrhosis (histological proof or obvious)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  HIV, HBV, HCV positive&#xD;
&#xD;
          -  Known Homozygotia (C282Y+/+)&#xD;
&#xD;
          -  Important hepatocytary iron overload for patient with resection&#xD;
&#xD;
          -  HCC non histologically prooved&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nantes UH</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jean Verdier UH</name>
      <address>
        <city>Paris</city>
        <zip>75000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paul Brousse UH</name>
      <address>
        <city>Paris</city>
        <zip>75000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rennes UH</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 8, 2010</study_first_submitted>
  <study_first_submitted_qc>February 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2010</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Liver Cirrhosis, Alcoholic</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

